布基纳法索、尼日利亚和乌干达疟疾诊断与管理可行性:一项社区观察性研究
在3个非洲国家172个村庄,训练社区卫生工作者用HRP2快速诊断试纸评估6月龄至6岁儿童,能口服者用青蒿素联合疗法、不能口服者用直肠青蒿琥酯并转诊,干预12个月。干预后以社区卫生工作者为首诊点的几率翻倍,RDT使用率从3.2%升至72.9%,无并发症和重症发作持续时间缩短,危险征象儿童比例从24.7%降至18.1%。
要点
- 训练社区卫生工作者用RDT诊断并按口服或直肠青蒿琥酯分流可提高疟疾诊治可及性。
- 干预后RDT使用率由3.2%升至72.9%,以社区卫生工作者为首诊点的OR为2.15。
- 无并发症和重症发作持续时间缩短,危险征象比例由24.7%降至18.1%。
核心结论
- 通过训练社区卫生工作者提供诊断和治疗,可增加疟疾诊治可及性、缩短临床发作持续时间并减少重症病例。
研究设计与样本
- 在3个非洲国家172个村庄开展社区观察性研究,训练社区卫生工作者用HRP2快速诊断试纸评估6月龄至6岁儿童。
- 干预组合包持续12个月,干预前后分别完成1746份和3199份随机家庭访谈以评估可及性、速度和临床病程。
主要发现
- 符合直肠青蒿琥酯条件的儿童占1.1%的发作。
- 以社区卫生工作者为首诊点的几率翻倍(OR 2.15,95%CI 1.9-2.4,P<.0001),RDT使用率从3.2%升至72.9%(OR 80.8,95%CI 51.2-127.3,P<.0001)。
- 无并发症发作平均持续时间从3.69±2.06天降至3.47±1.61天(df=2960,t=3.2,P=.0014),重症发作从4.24±2.26天降至3.7±1.57天(df=749,t=3.8,P=.0001),危险征象儿童从24.7%降至18.1%(OR 0.68,95%CI .59-.78,P<.0001)。
关键数值与推荐
- 能口服药物者使用青蒿素联合疗法,不能口服者使用直肠青蒿琥酯并转诊医院。
临床怎么用
- 在疟疾流行区可依托训练的社区卫生工作者用HRP2-RDT进行诊断,并按口服或直肠青蒿琥酯路径分流治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malaria-endemic countries are encouraged to increase, expedite, and standardize care based on parasite diagnosis and treat confirmed malaria using oral artemisinin-based combination therapy (ACT) or rectal artesunate plus referral when patients are unable to take oral medication. METHODS: In 172 villages in 3 African countries, trained community health workers (CHWs) assessed and diagnosed children aged between 6 months and 6 years using rapid histidine-rich protein 2 (HRP2)-based diagnostic tests (RDTs). Patients coming for care who could take oral medication were treated with ACTs, and those who could not were treated with rectal artesunate and referred to hospital. The full combined intervention package lasted 12 months. Changes in access and speed of care and clinical course were determined through 1746 random household interviews before and 3199 during the intervention. RESULTS: A total of 15 932 children were assessed: 6394 in Burkina Faso, 2148 in Nigeria, and 7390 in Uganda. Most children assessed (97.3% [15 495/15 932]) were febrile and most febrile cases (82.1% [12 725/15 495]) tested were RDT positive. Almost half of afebrile episodes (47.6% [204/429]) were RDT positive. Children eligible for rectal artesunate contributed 1.1% of episodes. The odds of using CHWs as the first point of care doubled (odds ratio [OR], 2.15; 95% confidence interval [CI], 1.9-2.4; P < .0001). RDT use changed from 3.2% to 72.9% (OR, 80.8; 95% CI, 51.2-127.3; P < .0001). The mean duration of uncomplicated episodes reduced from 3.69 ± 2.06 days to 3.47 ± 1.61 days, Degrees of freedom (df) = 2960, Student's t (t) = 3.2 (P = .0014), and mean duration of severe episodes reduced from 4.24 ± 2.26 days to 3.7 ± 1.57 days, df = 749, t = 3.8, P = .0001. There was a reduction in children with danger signs from 24.7% before to 18.1% during the intervention (OR, 0.68; 95% CI, .59-.78; P < .0001). CONCLUSIONS: Provision of diagnosis and treatment via trained CHWs increases access to diagnosis and treatment, shortens clinical episode duration, and reduces the number of severe cases. This approach, recommended by the World Health Organization, improves malaria case management. CLINICAL TRIALS REGISTRATION: ISRCTN13858170.
引用
- Ajayi IO, Nsungwa-Sabiiti J, Siribié M, et al. Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study. Clin Infect Dis. 2016. PMID: 27941101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。